ARQT
Arcutis Biotherapeutics, Inc. · Healthcare
Director Howard G. Welgus sold $116K of Arcutis Biotherapeutics, Inc.
Sold$116,281
$24.58Price
4,731Shares
−11%Stake
What ARQT did after the filing
- The stock from Thu, Jun 18 open, $26.69
- −2.8%
- S&P 500, same days
- +1.3%
Measured over 30 trading days, to the Aug 3 close.
Traded Mon, Jun 15. Filed Wed, Jun 17, 8:40 PM ET, after the close. Returns use the Jun 18 open and the Aug 3 close. Not investment advice.